Christopher D. Corsico, MD, MPH, is the Global Head of Development at GSK, responsible for development oversight of GSK’s late-stage portfolio though the end of the portfolio life cycle.

Prior to joining GSK, Chris worked at Boehringer Ingelheim for over 20 years in various roles, including as Global Head of Medicine and Chief Medical Officer.

Chris was a Howard Hughes Medical scholar prior to receiving his medical degree from the Cornell University College of Medicine in New York City and his MPH from the School of Public Health at Yale University in New Haven, Connecticut.

Chris trained in Internal Medicine at the Johns Hopkins University School of Medicine. He practiced Internal Medicine at the Johns Hopkins Medical Clinical and was an Assistant Professor of Internal Medicine at the Dartmouth Hitchcock Medical Centre and Dartmouth Medical School prior to joining the industry.